Anti-cancer effects of cinnamon: Insights into its apoptosis effects
Cancer is known as a leading cause of death worldwide. In the last two decades, the incidence of cancer has been dramatically increased mostly due to lifestyle changes. The importance of this issue has attracted further attention to discover novel therapies to prevent and treat cancers. According to...
Saved in:
Published in: | European journal of medicinal chemistry Vol. 178; pp. 131 - 140 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
France
Elsevier Masson SAS
15-09-2019
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Cancer is known as a leading cause of death worldwide. In the last two decades, the incidence of cancer has been dramatically increased mostly due to lifestyle changes. The importance of this issue has attracted further attention to discover novel therapies to prevent and treat cancers. According to previous studies, drugs used to treat cancer have shown significant limitations. Therefore, the role of herbal medicines alone or in combination with chemotherapy drugs has been extensively studied in cancer treatment. Cinnamon is a natural component showing a wide range of pharmacological functions including anti-oxidant, anti-microbial and anti-cancer activities. Impaired apoptosis plays critical roles in the initiation and progression of cancer. Increasing evidence indicates that cinnamon, as a therapeutic agent, has anti-cancer effects via affecting numerous apoptosis-related pathways in cancer cells. Here, we highlighted anticancer properties of cinnamon, particularly through targeting apoptosis-related mechanisms.
[Display omitted]
•Cinnamon and its analogues shows anti-cancer impacts via affecting on numerous cancer-related pathways such as apoptosis.•Inhibition of apoptosis is very common mechanism for escaping cancer cells from death.•Cinnamon and its analogues exert anti—apoptosis impacts on cancer cells via targeting Fas/CD95, caspase-3, and Bcl-XL. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ISSN: | 0223-5234 1768-3254 |
DOI: | 10.1016/j.ejmech.2019.05.067 |